Company news
PreveCeutical Medical Inc news in 2026
PreveCeutical Medical Inc's news releases, calls and decks from 2026, newest first.
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
October 22, 2026
PreveCeutical Closes Fourth Tranche of Non-Brokered Private Placement
August 4, 2026
PreveCeutical Closes Third Tranche of Non-Brokered Private Placement
July 27, 2026
PreveCeutical Announces Extension of Non-Brokered Private Placement
May 19, 2026
PreveCeutical Medical Closes Initial Tranche of Non-Brokered Private Placement
May 12, 2026
PreveCeutical Adopts Semi-Annual Financial Reporting
April 1, 2026
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 30, 2026
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
February 25, 2026
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
February 9, 2026
Decks in 2026
- BioGene Therapeutics — Investor Presentation (June 2026)
Investor deck · 41 slides · Jun 12, 2026
- Investor Presentation (April 2026)
Investor deck · 28 slides · April 2026
- Investor Presentation (April 2026)
Investor deck · 26 slides · April 2026
- Investor Presentation (April 2026)
Investor deck · 22 slides · April 2026
- Investor Presentation (April 2026)
Investor deck · 24 slides · April 2026
- Investor Presentation (January 2026)
Investor deck · 23 slides · January 2026
- Investor Presentation (January 2026)
Investor deck · 21 slides · January 2026
- Investor Presentation (January 2026)
Investor deck · 27 slides · January 2026